First Trust Advisors
IMVT icon

First Trust Advisors’s Immunovant IMVT Stock Holding History

First Trust Advisors’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Buy
+5,405
New +$165K ﹤0.01% 2596
2024
Q2 		– Sell
-33,306
Closed -$1.08M – 2374
2024
Q1 		$1.08M Sell
33,306
-4,586
-12% -$167K ﹤0.01% 1963
2023
Q4 		$1.6M Buy
+37,892
New +$1.39M ﹤0.01% 1815

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors's IMVT Position: Q2 2026 in Review

First Trust Advisors opened a new position in Immunovant (IMVT) in Q2 2026: 5,405 shares worth $208K. The stake represents ﹤0.01% of the portfolio and ranks #2596 among its holdings. This is a return to the name: First Trust Advisors previously reported a position in IMVT as recently as Q1 2024.

First Trust Advisors first reported a position in IMVT in Q4 2023 and has held it in 3 quarters since. The position peaked at $1.6M in Q4 2023. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • First Trust Advisors held 5,405 shares of Immunovant worth $208K as of Q2 2026.
  • Immunovant was a new First Trust Advisors position in Q2 2026.
  • Immunovant made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #2596 holding.
  • First Trust Advisors first reported a position in Immunovant in Q4 2023 and has held it in 3 quarters since.
  • First Trust Advisors's Immunovant position peaked at $1.6M in Q4 2023.
  • 227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.